XFOR — X4 Pharmaceuticals, Inc. stock price, charts and financials

QT66X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.29
+0.20+4.89%
OverviewShort InterestFilings
XFORQT66X4 Pharmaceuticals, Inc.·NASDAQ
4.29+4.89%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 2026SC 13GBeneficial ownership statement (passive)
Jul 01, 20268-KCurrent report
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20263Initial statement of beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 2026EFFECTNotice of effectiveness
May 13, 20268-K/ACurrent report (amended)
May 13, 20264Statement of changes in beneficial ownership
May 12, 20268-KCurrent report
May 06, 2026S-3Shelf registration statement
May 06, 202610-QQuarterly report
Mar 20, 2026DEFA14AAdditional proxy soliciting materials
Mar 20, 2026ARSAnnual report to shareholders
Mar 20, 2026DEF 14ADefinitive proxy statement
Mar 18, 2026S-8Registration of employee benefit securities
Mar 17, 202610-KAnnual report
Mar 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 17, 2026SC 13GBeneficial ownership statement (passive)
Feb 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 12, 2026SC 13GBeneficial ownership statement (passive)
Feb 05, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 395
Page
▼
/ 16